1. Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors. Issue 3 (13th March 2023) Authors: Lontos, Konstantinos; Wang, Yiyang; Joshi, Supriya K; Frisch, Andrew T; Watson, McLane J; Kumar, Alok; Menk, Ashley V; Wang, Yupeng; Cumberland, Rachel; Lohmueller, Jason; Carrizosa, Esteban; Boyerinas, Benjamin; Delgoffe, Greg M Journal: Journal for immunotherapy of cancer Issue: Volume 11:Issue 3(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗